Synapticure

Synapticure brings personalized care to you. Built by and for those living neurodegenerative diseases

12/16/2025

ALS took Nick's arm mobility. With his Neuralink device, he regained a level of independence he thought he'd lost forever.

His BCI (Brain-Computer Interface) connects his brain to a robotic arm that allows him to gesture, microwave food, and grab a cup of water again.

Talk to a Synapticure physician virtually to discuss trials and expanded access programs: synapticure.com

Watch the full event recording here: https://vist.ly/4isxt

12/12/2025

Meet Brad, the third person in the world to receive a Neuralink brain implant. Brad lost his voice to ALS. Neuralink has given that back, and with it, the ability to reconnect with his loved ones.

Talk to a Synapticure physician virtually to discuss trials and expanded access programs: synapticure.com

Watch the full event recording here: https://vist.ly/4ic7v

12/10/2025

"ALS hits you like a pound of bricks. But having this opportunity for my generation is like the equivalent to being one of the first ones on the moon."

Jake is a Neuralink clinical trial participant helping develop new ways to type for others that have lost mobility in their arms. He’s in the process of writing a book about his story – using just his thoughts.

Talk to a Synapticure physician virtually to discuss trials and expanded access programs: synapticure.com

Watch the full event recording here: https://vist.ly/4h2f6

12/05/2025

Recently, we hosted a webinar with Neuralink , and interviewed three ALS patients actively participating in Neuralink clinical trials. Brad, Jake, and Nick walk us through some common misconceptions people have around BCI (Brain-Computer Interface) technology.

Talk to a Synapticure physician virtually to discuss trials and expanded access programs: synapticure.com

Watch the full event recording here: https://vist.ly/4her8

11/25/2025

November is National Family Caregivers Month—a time to shine a light on the compassion and commitment of those who care for others, often without recognition. This month, we’re excited to celebrate one of our own: Synapticure Care Navigator, Sabrina Johnson, whose dedication makes a profound difference every day.

As a family caregiver herself, Sabrina is all too familiar with the challenges caregivers face. She knows what it's like to navigate the questions, the exhaustion, and the search for hope. In a recent blog post, she breaks down Emma Heming Willis , The Unexpected Journey, and how it guides caregivers as they learn to balance self-care, with their loved one's diagnosis.

Find a copy at: https://vist.ly/4fz75
Read Sabrina's full post: Link in bio

11/18/2025

Quality care shouldn't be reserved for a select few, and traveling to see specialists can be an expensive operation.

Synapticure offers access to these experts—all from the comfort of home.

10/31/2025

🗞️ Big news: our co-founder & CEO, Sandra Abrevaya, has been recognized in the latest Notable Leaders in Health Care Technology list by Crain's Chicago Business Business. She was recognized alongside 26 other champions of the patient movement.

Thank you to everyone who continues to support the Synapticure mission to transform the standard of care and treatment for those living with neurodegenerative diseases. 💙

10/28/2025

Look forward to seeing everyone shortly to meet with ALS patients who in Neuralink It Solutions Inc's BCI study and learn how they're using it to today.

Register here to join or receive the video. https://vist.ly/4b2p9

10/24/2025

Brain Computer Interfaces (BCI) has the chance to restore the little things we take for granted as healthy adults every day -- communication, moving a mouse, and hopefully someday replacing lost control of movement. We are grateful to host three patients in Neuralink's ALS trial for webinar on October 28th at 2PM ET with representatives from , and to build awareness for this and other upcoming clinical trials.

Register for the webinar here. https://synapticure.zoom.us/webinar/register/WN__a_f8PE-QTyr9FVJMNDk3w #/registration

Click the link above to register and connect with patients who are using Neuralink today to hear about their journey to BCI, their decision to join the trial, and how it has changed their lives. Please feel free to submit questions in advance in the registration link.

10/21/2025

Synapticure is excited to share that we will be hosting a webinar on 10/28 with participants in the Neuralink ongoing ALS trial, along with representatives from the company. The webinar will feature Brad Smith, Jake Schneider, and Nick Wray—three individuals with ALS participating in Neuralink’s clinical trials to explore the use of BCI technology in their daily lives.

In the webinar we will discuss the technology, the decisions patients make to participate in studies around BCI technology, and connect with patients who have enrolled in the study and are using Neuralink today. To register for the Webinar, click here.

We hope to see you on the 28th! Register here to attend, ask questions and / or receive the recording.

https://synapticure.zoom.us/webinar/register/WN__a_f8PE-QTyr9FVJMNDk3w

10/03/2025

Synapticure’s Clinical Research team, led by Abigail O’Connell and Eric Anderson, is excited to join the NEALS Annual Conference next week in Clearwater, Florida October 7-10th!

We’re looking forward to connecting with colleagues and collaborators to discuss how Synapticure is expanding remote access to research participation for people living with ALS—helping patients enroll and stay engaged in trials regardless of where they live.

We’ll also be presenting a poster with our colleagues at Clene Nanomedicine and Jinsy Andrews:
“A Comparison of Baseline Clinical Characteristics Between Decentralized and Institutionally-Enrolled Participants in the CNM-Au8 EAP04 Study”

If you’ll be at NEALS, we’d love to connect—whether to discuss partnerships, share insights, or explore how we can work together to bring more inclusive research opportunities to ALS patients everywhere.

Reach out to partners@synapticure.com for more information or to schedule a meeting

09/09/2025

We’re thrilled to share that our CEO & Co-Founder, Sandra Abrevaya, will be a featured keynote speaker at the New York Brain-Computer Interface Symposium ( ) on October 3-4 in New York City!

Sandra will present “The Power of Advocacy: Driving BCI Forward,” highlighting how patient voices and advocacy guide research, shape policy, and keep people at the center of innovation.

We’re honored to be part of this global conversation and can’t wait to share what’s ahead in .

Address

2045 W Grand Avenue Ste B
Chicago, IL
60612

Website

https://www.synapticure.com/

Alerts

Be the first to know and let us send you an email when Synapticure posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Synapticure:

Shortcuts

Want your practice to be the top-listed Clinic in Chicago?